Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 22
503
Views
9
CrossRef citations to date
0
Altmetric
Short Communications

Antiproliferative activity of carotenoid pigments produced by extremophile bacteria

, , , , , & show all
Pages 4638-4642 | Received 12 Jul 2019, Accepted 17 Nov 2019, Published online: 06 Dec 2019

References

  • Abbes M, Baati H, Guermazi S, Messina C, Santulli A, Gharsallah N, Ammar E.2013. Biological properties of carotenoids extracted from Halobacterium halobium isolated from a Tunisian solar saltern. BMC Complement. Altern Med. 13:255–262.
  • Choi Y, Hur J, Lim S, Jo M, Kim D, Choi J. 2014. Induction of apoptosis by deinoxanthin in human cancer cells. Anticancer. Res. 34(4):1829–1836. pp
  • D’Alessandro M, Mancini A. 2013. Crocus sativus stigma extract and its major constituent crocin possess significant antiproliferative properties against human prostate cancer. Nutr Cancer. 65(6):930–942.
  • De Maayer P, Anderson D, Cary C, Cowan DA. 2014. Some like it cold: understanding the survival strategies of psychrophiles. EMBO Rep. 15(5):508–517.
  • Dieser M, Greenwood M, Foreman C. 2010. Carotenoid pigmentation in Antarctic heterotrophic bacteria as a strategy to withstand environmental stresses. Arct Antarct Alp Res. 42(4):396–405.
  • Eid S, El-Readi M, Wink M. 2012. Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters. Phytomedicine. 19(11):977–987.
  • Graat HCA, Witlox MA, Schagen FHE, Kaspers GJL, Helder MN, Bras J, Schaap GR, Gerritsen WR, Wuisman P, Van Beusechem VW. 2006. Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin. Br J Cancer. 94(12):1837
  • Kirti K, Amita S, Priti S, Kumar A, Jyoti S. 2014. Colorful world of microbes: carotenoids and their applications. Adv Biol. 2014:13.
  • Kotake-Nara E, Asai A, Nagao A. 2005. Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells. Cancer Lett. 220(1):75–84.
  • Liu C, Lim Y, Hu M. 2013. Fucoxanthin enhances cisplatin-induced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells. Mar Drugs. 11(12):50–66.
  • Palozza P, Torelli C, Boninsegna A, Simone R, Catalano A, Mele MC, Picci N. 2009. Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells. Cancer Lett. 283(1):108–117.
  • Pasquet V, Morisset P, Ihammouine S, Chepied A, Aumailley L, Berard J, Serive B, Kaas R, Lanneluc I, Thiery V, et al. 2011. Antiproliferative activity of violaxanthin isolated from bioguided fractionation of Dunaliella tertiolecta extracts. Mar Drugs. 9(5):819–831.
  • Raddadi N, Cherif A, Daffonchio D, Neifar M, Fava F. 2015. Biotechnological applications of extremophiles, extremozymes and extremolytes. Appl Microbiol Biotechnol. 99(19):7907–7913.
  • Suberu JO, Romero‐Canelón I, Sullivan N, Lapkin AA, Barker GC. 2014. Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells. ChemMedChem. 9(12):2791–2797.
  • Sutthiwong N, Dufosse L. 2014. Production of carotenoids by Arthrobacter arilaitensis strains isolated from smear-ripened cheeses. FEMS Microbiol Lett. 360(2):174–181.
  • Tian B, Hua Y. 2010. Carotenoid biosynthesis in extremophilic Deinococcus-Thermus bacteria. Trends Microbiol. 18(11):512–520.
  • Venil C, Zakaria Z, Ahmad W. 2013. Bacterial pigments and their applications. Process Biochem. 48(7):1065–1079.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.